Overview
Hans Clevers is a organoid biology specialist with an H-index of 261 at Hubrecht Institute (Faculty). Has been published in Nature, Cell, Science. Based in Netherlands.
Biography
Johannes (Hans) Carolus Clevers is a Dutch molecular geneticist, cell biologist and stem cell researcher. He became the Head of Pharma, Research and Early Development, and a member of the Corporate Executive Committee, of the Swiss healthcare company Roche in 2022. Previously, he headed a research group at the Hubrecht Institute for Developmental Biology and Stem Cell Research and at the Princess Máxima Center; he remained as an advisor and guest scientist or visiting researcher to both groups. He is also a Professor in Molecular Genetics at Utrecht University.
Affiliations & Institutions
Research Impact
5 Publications
0 Total Citations
Published In
CellJ Exp Med
Key Publications
A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity.
Modeling Development and Disease with Organoids.
Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities.
Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer.
Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids.
Areas of Expertise
Medical Specialties
Media Archive